ARTIVION INC (AORT) Fundamental Analysis & Valuation

NYSE:AORT • US2289031005

Current stock price

37.47 USD
-0.48 (-1.26%)
At close:
37.47 USD
0 (0%)
After Hours:

This AORT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. AORT Profitability Analysis

1.1 Basic Checks

  • AORT had positive earnings in the past year.
  • AORT had a positive operating cash flow in the past year.
  • In the past 5 years AORT reported 4 times negative net income.
  • In multiple years AORT reported negative operating cash flow during the last 5 years.
AORT Yearly Net Income VS EBIT VS OCF VS FCFAORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • AORT has a Return On Assets of 1.10%. This is in the better half of the industry: AORT outperforms 72.34% of its industry peers.
  • AORT has a better Return On Equity (2.18%) than 72.87% of its industry peers.
  • AORT has a better Return On Invested Capital (2.26%) than 69.68% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AORT is significantly below the industry average of 9.15%.
Industry RankSector Rank
ROA 1.1%
ROE 2.18%
ROIC 2.26%
ROA(3y)-1.48%
ROA(5y)-1.76%
ROE(3y)-4.5%
ROE(5y)-5.02%
ROIC(3y)2.51%
ROIC(5y)N/A
AORT Yearly ROA, ROE, ROICAORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10

1.3 Margins

  • AORT's Profit Margin of 2.21% is fine compared to the rest of the industry. AORT outperforms 72.87% of its industry peers.
  • AORT has a better Operating Margin (6.06%) than 72.34% of its industry peers.
  • AORT's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 64.40%, AORT is in the better half of the industry, outperforming 69.68% of the companies in the same industry.
  • AORT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.06%
PM (TTM) 2.21%
GM 64.4%
OM growth 3YN/A
OM growth 5Y12.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.57%
AORT Yearly Profit, Operating, Gross MarginsAORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. AORT Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AORT is destroying value.
  • The number of shares outstanding for AORT has been increased compared to 1 year ago.
  • Compared to 5 years ago, AORT has more shares outstanding
  • Compared to 1 year ago, AORT has an improved debt to assets ratio.
AORT Yearly Shares OutstandingAORT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AORT Yearly Total Debt VS Total AssetsAORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • AORT has an Altman-Z score of 3.36. This indicates that AORT is financially healthy and has little risk of bankruptcy at the moment.
  • AORT has a better Altman-Z score (3.36) than 69.68% of its industry peers.
  • AORT has a debt to FCF ratio of 260.47. This is a negative value and a sign of low solvency as AORT would need 260.47 years to pay back of all of its debts.
  • The Debt to FCF ratio of AORT (260.47) is better than 64.36% of its industry peers.
  • A Debt/Equity ratio of 0.49 indicates that AORT is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.49, AORT is not doing good in the industry: 60.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 260.47
Altman-Z 3.36
ROIC/WACC0.26
WACC8.65%
AORT Yearly LT Debt VS Equity VS FCFAORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • AORT has a Current Ratio of 3.53. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
  • AORT has a Current ratio of 3.53. This is comparable to the rest of the industry: AORT outperforms 57.98% of its industry peers.
  • A Quick Ratio of 2.62 indicates that AORT has no problem at all paying its short term obligations.
  • AORT has a Quick ratio of 2.62. This is comparable to the rest of the industry: AORT outperforms 57.45% of its industry peers.
Industry RankSector Rank
Current Ratio 3.53
Quick Ratio 2.62
AORT Yearly Current Assets VS Current LiabilitesAORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AORT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 141.86% over the past year.
  • AORT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.78% yearly.
  • AORT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.59%.
  • Measured over the past years, AORT shows a quite strong growth in Revenue. The Revenue has been growing by 11.75% on average per year.
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y12.04%
Revenue growth 5Y11.75%
Sales Q2Q%19.2%

3.2 Future

  • Based on estimates for the next years, AORT will show a very strong growth in Earnings Per Share. The EPS will grow by 70.33% on average per year.
  • The Revenue is expected to grow by 12.25% on average over the next years. This is quite good.
EPS Next Y143.83%
EPS Next 2Y107.21%
EPS Next 3Y69.87%
EPS Next 5Y70.33%
Revenue Next Year11.86%
Revenue Next 2Y11.51%
Revenue Next 3Y11.73%
Revenue Next 5Y12.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AORT Yearly Revenue VS EstimatesAORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
AORT Yearly EPS VS EstimatesAORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. AORT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 208.17 indicates a quite expensive valuation of AORT.
  • Compared to the rest of the industry, the Price/Earnings ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 63.83% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.38. AORT is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 85.37, which means the current valuation is very expensive for AORT.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 65.96% of the companies listed in the same industry.
  • AORT is valuated expensively when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 208.17
Fwd PE 85.37
AORT Price Earnings VS Forward Price EarningsAORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 67.55% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 64.36% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2166.02
EV/EBITDA 40.06
AORT Per share dataAORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • AORT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • AORT's earnings are expected to grow with 69.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.45
PEG (5Y)N/A
EPS Next 2Y107.21%
EPS Next 3Y69.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AORT Dividend Analysis

5.1 Amount

  • AORT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AORT Fundamentals: All Metrics, Ratios and Statistics

ARTIVION INC

NYSE:AORT (4/15/2026, 8:04:00 PM)

After market: 37.47 0 (0%)

37.47

-0.48 (-1.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners88.52%
Inst Owner Change0%
Ins Owners4.4%
Ins Owner Change5.62%
Market Cap1.82B
Revenue(TTM)441.33M
Net Income(TTM)9.76M
Analysts83.08
Price Target52.46 (40.01%)
Short Float %3.75%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)101.61%
Min EPS beat(2)-39.98%
Max EPS beat(2)243.19%
EPS beat(4)3
Avg EPS beat(4)555.79%
Min EPS beat(4)-39.98%
Max EPS beat(4)1928.24%
EPS beat(8)5
Avg EPS beat(8)220.91%
EPS beat(12)7
Avg EPS beat(12)112.9%
EPS beat(16)11
Avg EPS beat(16)108.2%
Revenue beat(2)0
Avg Revenue beat(2)-1.72%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)-1.12%
Revenue beat(4)2
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)2.59%
Revenue beat(8)3
Avg Revenue beat(8)-0.34%
Revenue beat(12)7
Avg Revenue beat(12)0.64%
Revenue beat(16)9
Avg Revenue beat(16)0.45%
PT rev (1m)0%
PT rev (3m)-0.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.22%
EPS NY rev (1m)20.38%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 208.17
Fwd PE 85.37
P/S 4.12
P/FCF 2166.02
P/OCF 45.57
P/B 4.05
P/tB 48.27
EV/EBITDA 40.06
EPS(TTM)0.18
EY0.48%
EPS(NY)0.44
Fwd EY1.17%
FCF(TTM)0.02
FCFY0.05%
OCF(TTM)0.82
OCFY2.19%
SpS9.1
BVpS9.24
TBVpS0.78
PEG (NY)1.45
PEG (5Y)N/A
Graham Number6.11798 (-83.67%)
Profitability
Industry RankSector Rank
ROA 1.1%
ROE 2.18%
ROCE 3.41%
ROIC 2.26%
ROICexc 2.46%
ROICexgc 5.74%
OM 6.06%
PM (TTM) 2.21%
GM 64.4%
FCFM 0.19%
ROA(3y)-1.48%
ROA(5y)-1.76%
ROE(3y)-4.5%
ROE(5y)-5.02%
ROIC(3y)2.51%
ROIC(5y)N/A
ROICexc(3y)2.72%
ROICexc(5y)N/A
ROICexgc(3y)6.7%
ROICexgc(5y)N/A
ROCE(3y)3.8%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y12.65%
ROICexc growth 3YN/A
ROICexc growth 5Y23.53%
OM growth 3YN/A
OM growth 5Y12.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.57%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 260.47
Debt/EBITDA 4.43
Cap/Depr 173.84%
Cap/Sales 8.85%
Interest Coverage 0.95
Cash Conversion 81.05%
Profit Quality 8.6%
Current Ratio 3.53
Quick Ratio 2.62
Altman-Z 3.36
F-Score7
WACC8.65%
ROIC/WACC0.26
Cap/Depr(3y)84.09%
Cap/Depr(5y)70.92%
Cap/Sales(3y)4.61%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
EPS Next Y143.83%
EPS Next 2Y107.21%
EPS Next 3Y69.87%
EPS Next 5Y70.33%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y12.04%
Revenue growth 5Y11.75%
Sales Q2Q%19.2%
Revenue Next Year11.86%
Revenue Next 2Y11.51%
Revenue Next 3Y11.73%
Revenue Next 5Y12.25%
EBIT growth 1Y-0.48%
EBIT growth 3YN/A
EBIT growth 5Y25.35%
EBIT Next Year219.45%
EBIT Next 3Y65.89%
EBIT Next 5Y45.21%
FCF growth 1Y-92.41%
FCF growth 3YN/A
FCF growth 5Y-30.14%
OCF growth 1Y79.35%
OCF growth 3YN/A
OCF growth 5Y26.38%

ARTIVION INC / AORT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARTIVION INC?

ChartMill assigns a fundamental rating of 5 / 10 to AORT.


What is the valuation status for AORT stock?

ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.


What is the profitability of AORT stock?

ARTIVION INC (AORT) has a profitability rating of 5 / 10.


What is the financial health of ARTIVION INC (AORT) stock?

The financial health rating of ARTIVION INC (AORT) is 5 / 10.


Can you provide the expected EPS growth for AORT stock?

The Earnings per Share (EPS) of ARTIVION INC (AORT) is expected to grow by 143.83% in the next year.